Gay and Bisexual Men’s Strategies to Maintain Daily Adherence to Their HIV Pre-exposure Prophylaxis (PrEP) Medication: Results from a Qualitative Study

被引:0
作者
Christian Grov
Anthony W. P. Flynn
Alexa B. D’Angelo
Javier Lopez-Rios
David W. Pantalone
Ian W. Holloway
Jeffrey T. Parsons
机构
[1] CUNY Graduate School of Public Health and Health Policy,Department of Community Health and Social Sciences
[2] CUNY Institute for Implementation Science in Population Health (ISPH),Department of Counseling Psychology
[3] University of Wisconsin Madison,Department of Social Welfare
[4] University of Massachusetts Boston,Hunter College of CUNY, The Center for HIV/AIDS Educational Studies and Training (CHEST)
[5] University of California Los Angeles,undefined
[6] The Graduate Center of CUNY,undefined
来源
Prevention Science | 2019年 / 20卷
关键词
Pre-exposure prophylaxis (PrEP); Adherence; Gay and bisexual men; HIV; Qualitative data;
D O I
暂无
中图分类号
学科分类号
摘要
Since FDA approval in 2012, HIV pre-exposure prophylaxis (PrEP) has been adopted by key populations, including gay and bisexual men (GBM), to reduce their HIV transmission risk. Given that PrEP is optimally effective when taken as prescribed, it is critical to understand the adherence strategies GBM use. We conducted one-on-one, semi-structured interviews with GBM taking PrEP in 2015–2016 (n = 103). Using thematic analysis, we identified six adherence strategies, with most participants (84.3%) utilizing multiple strategies to maintain adequate adherence: (1) integrating PrEP into part of a daily routine, (2) using a pillbox, (3) cognitive strategies/visual cues, (4) setting recurring smartphone alarms or reminders, (5) keeping medication on oneself at all times, and (6) partner or peer support for reminders and/or pill sharing. Overall, participants reported high PrEP adherence (M = 1.6 missed doses in the prior 30 days), though nearly all described missing at least one dose unintentionally in the past. Participants credited their high levels of adherence in part to the strategies they adopted. Providers working with GBM prescribed PrEP, especially patients reporting difficulties with adherence, might consider recommending any or all of the six strategies described in this study.
引用
收藏
页码:168 / 177
页数:9
相关论文
共 180 条
  • [1] Atreja A(2005)Strategies to enhance patient adherence: Making it simple Medscape General Medicine 7 4-424
  • [2] Bellam N(2014)Effect of drug reminder packaging on medication adherence: a systematic review revealing research gaps Systematic Reviews 3 29-S204
  • [3] Levy SR(2011)Medication adherence: a call for action American Heart Journal 162 412-399
  • [4] Boeni F(2014)Interventions to improve adherence to antiretroviral therapy: a rapid systematic review AIDS 28 S187-566
  • [5] Spinatsch E(2003)Interventions to improve antipsychotic medication adherence: Review of recent literature Journal of Clinical Psychopharmacology 23 389-e406
  • [6] Suter K(2014)Two years of Truvada for pre-exposure prophylaxis utilization in the US Journal of the International AIDS Society 17 19730-254
  • [7] Hersberger KE(2013)Participant experiences and facilitators and barriers to pill use among men who have sex with men in the iPrEx Pre-Exposure Prophylaxis Trial in San Francisco AIDS Patient Care and STDs 27 560-418
  • [8] Arnet I(2016)Pharmacology supports “on-demand” PrEP The lancet. HIV 3 e405-829
  • [9] Bosworth HB(2013)From efficacy to effectiveness: Facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City AIDS Patient Care and STDs 27 248-17
  • [10] Granger BB(2004)Social support, positive states of mind, and HIV treatment adherence in men and women living with HIV/AIDS Health Psychology 23 413-1721